SREBF and miR33 in cholesterol and lipid homeostasis (WP2084)

Mus musculus

Open in new tab Open in Newt (SBGN)
Download PNG Download SVG Download JSON Download GPML Learn more about Downloads
This pathway describes transcription factor-microRNA circuits governing cholesterol and lipid homeostasis. It is based on a seminar by Dr. Anders Näär.

Authors

Linda Rieswijk and Lars Willighagen

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Mus musculus

Communities

Annotations

Pathway Ontology

homeostasis pathway

Participants

Label Type Compact URI Comment
Srebf1 GeneProduct ensembl:ENSMUSG00000020538
Ppargc1a GeneProduct ensembl:ENSMUSG00000029167
Sirt6 GeneProduct ensembl:ENSMUSG00000034748
Hmgcr GeneProduct ensembl:ENSMUSG00000021670
Sirt1 GeneProduct ensembl:ENSMUSG00000020063
Mtor GeneProduct ensembl:ENSMUSG00000028991
Nr1h3 GeneProduct ensembl:ENSMUSG00000002108
Ppara GeneProduct ensembl:ENSMUSG00000022383
Mir33 GeneProduct ensembl:ENSMUSG00000065465
Med15 GeneProduct ensembl:ENSMUSG00000012114
Srebf2 GeneProduct ensembl:ENSMUSG00000022463
Hmgcs1 GeneProduct ensembl:ENSMUSG00000079301
Ldlr GeneProduct ensembl:ENSMUSG00000032193

References

  1. An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Yang F, Vought BW, Satterlee JS, Walker AK, Jim Sun ZY, Watts JL, et al. Nature. 2006 Aug 10;442(7103):700–4. PubMed Europe PMC Scholia
  2. Receptor feasts on sugar and cholesterol. Rodgers JT, Puigserver P. Nat Med. 2007 Feb;13(2):128–9. PubMed Europe PMC Scholia
  3. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, et al. EMBO J. 2007 Apr 4;26(7):1913–23. PubMed Europe PMC Scholia
  4. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, et al. EMBO J. 2007 Jul 11;26(13):3169–79. PubMed Europe PMC Scholia
  5. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Rodgers JT, Puigserver P. Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12861–6. PubMed Europe PMC Scholia
  6. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. Nature. 2007 Nov 29;450(7170):736–40. PubMed Europe PMC Scholia
  7. Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Walker AK, Yang F, Jiang K, Ji JY, Watts JL, Purushotham A, et al. Genes Dev. 2010 Jul 1;24(13):1403–17. PubMed Europe PMC Scholia
  8. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. Gerin I, Clerbaux LA, Haumont O, Lanthier N, Das AK, Burant CF, et al. J Biol Chem. 2010 Oct 29;285(44):33652–61. PubMed Europe PMC Scholia
  9. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, et al. Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17321–6. PubMed Europe PMC Scholia